Thailand Launches Trial of Nasal-spray H5N1 Vaccine
HSS press release, Thursday 7 June 2012

Thailand today became one of the first countries in the world to test an H5N1 avian, or bird, influenza vaccine in a needle-free, nasal spray formulation. This Phase I clinical trial of a live attenuated influenza vaccine, known as LAIV, to protect people from the H5N1 virus, resulted from international collaboration with health agencies around the world, including the U.S. Department of Health and Human Services' Biomedical Advanced Research and Development Authority (BARDA). A Phase I clinical trial is the first step in testing new vaccines in humans.

read more...


 

H7N9 Cases by Age

Exposure to Animals

H7N9 Questions

Role of preventing AMR

FAO and AMR


Your Contribution

To submit an event, document or link, contact:

Dr. Katinka DeBalogh
Senior Animal Production and Health Officer
/APHCA Secretary

E-mail: This e-mail address is being protected from spambots. You need JavaScript enabled to view it

You are Visitor

mod_vvisit_countermod_vvisit_countermod_vvisit_countermod_vvisit_countermod_vvisit_countermod_vvisit_countermod_vvisit_countermod_vvisit_counter
mod_vvisit_counterToday406
mod_vvisit_counterYesterday1457
mod_vvisit_counterThis week3198
mod_vvisit_counterThis month9467
mod_vvisit_counterAll7639284

Origin of Visitors

Locations of visitors to this page

Follow Us on

FacebookFacebook
TwitterTwitter
YoutubeYoutube


Latest Publications